Cargando…

Generation of adherent lymphokine activated killer (A-LAK) cells from patients with acute myelogenous leukaemia.

Successful generation of adherent lymphokine-activated killer (A-LAK) cells, highly-enriched in CD3-CD56+ antitumour effector cells, from the peripheral blood of ten patients with acute myelogenous leukaemia (AML) is described. The AML patients were either untreated or in remission. In vitro prolife...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sedlmayr, P., Rabinowich, H., Winkelstein, A., Herberman, R. B., Whiteside, T. L.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1992
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977745/ https://www.ncbi.nlm.nih.gov/pubmed/1739621

Ejemplares similares

Suppression of the generation of lymphokine-activated killer (LAK) cells by serum-free supernatants of in vitro maintained tumour cell lines.
por: Guillou, P. J., et al.
Publicado: (1989)

Paradoxical effects of 5-FU/folinic acid on lymphokine-activated killer (LAK) cell induction in patients with colorectal cancer.
por: Onodera, H., et al.
Publicado: (1990)

Studies of lymphokine-activated killer (LAK) cells. I. Evidence using novel monoclonal antibodies that most human LAK precursor cells share a common surface marker
Publicado: (1989)

Accumulation of adoptively transferred adherent, lymphokine-activated killer cells in murine metastases
Publicado: (1991)

Immunotherapy for Acute Myelogenous Leukaemia
por: Powles, R. L., et al.
Publicado: (1973)

Myelogenic Leukaemia
Publicado: (1915)

Natural killer and lymphokine activated killer cell functions in Hodgkin's disease.
por: Rajaram, N., et al.
Publicado: (1990)

Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells
Publicado: (1989)

Lymphokine-activated killer cells. Analysis of progenitors and effectors
Publicado: (1986)

Characterization of Transendothelial Migratory Lymphokine‐activated Killer Cells
por: Nakano, Koji, et al.
Publicado: (1996)

Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells
Publicado: (1983)

Generation and Characterization of Lymphokine‐activated Killer Cells against Fresh Human Leukemia Cells
por: Tahara, Tohru, et al.
Publicado: (1988)

Enhanced lymphokine-activated killer cell activity by an immunomodulator, Roquinimex.
por: Vaz, F., et al.
Publicado: (1995)

Induction of lymphokine-activated killer-like cells by cancer chemotherapy
Publicado: (1988)

Establishment of Mouse Lymphokine‐activated Killer Cell Clones and Their Properties
por: Kato, Kazunori, et al.
Publicado: (1991)

The Heterogeneity of Target Recognition by Lymphokine‐activated Killer Precursor Cells
por: Ibayashi, Yukihiro, et al.
Publicado: (1990)

Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells
Publicado: (1988)

Myelogenous Leukæmia and Its Treatment
por: Debove,
Publicado: (1910)

Active immunotherapy in acute myelogenous leukaemia and the induction of second and subsequent remissions.
por: Harris, R., et al.
Publicado: (1978)

Factors influencing prognosis in adults with acute myelogenous leukaemia.
por: Crowther, D., et al.
Publicado: (1975)

Further evidence of response by leukaemia patients in remission to antigen(s) related to acute myelogenous leukaemia.
por: Cocks, P., et al.
Publicado: (1977)

Acquired resistance to daunorubicin in a patient with acute myelogenous leukaemia.
por: Smith, B. J., et al.
Publicado: (1976)

IMMUNOTHERAPY OF SOLID TOMOR BY INTRATUMORAL INFUSION OF LYMPHOKINE‐ACTIVATED KILLER CELLS
por: Yamaki, Toshiaki, et al.
Publicado: (1988)

Immunotherapy alone vs no maintenance treatment in acute myelogenous leukaemia.
por: Zuhrie, S. R., et al.
Publicado: (1980)

Interleukin 5 enhances interleukin 2-mediated lymphokine-activated killer activity
Publicado: (1989)

Immune activation by combination human lymphokine-activated killer and dendritic cell therapy
por: West, E J, et al.
Publicado: (2011)

A quantitative analysis of heterogeneities and hallmarks in acute myelogenous leukaemia
por: Hu, C. W., et al.
Publicado: (2019)

Enhancing Effect of Pokeweed Mitogen on the Proliferation and the Cytotoxicity of Lymphokine‐activated Killer Cells
por: Kimoto, Yasuhiko, et al.
Publicado: (1992)

Cytogenetic analysis of leukaemic colonies from acute and chronic myelogenous leukaemia.
por: Trent, J. M., et al.
Publicado: (1983)

Lymphokine‐activated Killer Induction and Its Regulation by Macrophages in Malignant Pleural Effusions
por: Yanagawa, Hiroaki, et al.
Publicado: (1989)

Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis
Publicado: (1986)

Interleukin 7 enhances cytolytic T lymphocyte generation and induces lymphokine-activated killer cells from human peripheral blood
Publicado: (1990)

Interaction of lymphokine-activated killer cells with susceptible targets does not induce second messenger generation and cytolytic granule exocytosis
Publicado: (1989)

Human lymphokine-activated killer cells are cytotoxic against cells infected with Toxoplasma gondii
Publicado: (1992)

Influence of transfusion of lymphokine-activated T killer cells on inflammatory responses in dogs after laparotomy
por: MIE, Keiichiro, et al.
Publicado: (2016)

Two Populations of Mouse Lymphokine‐activated Killer Cells Separated by Use of Soybean Agglutinin
por: Takano, Mariko, et al.
Publicado: (1989)

Lymphokines
por: Hamblin, Anne S
Publicado: (1998)

Lysis of allogeneic and autologous melanoma cells by IL-7-induced lymphokine-activated killer cells.
por: Böhm, M., et al.
Publicado: (1994)

Reinforced Cytotoxicity of Lymphokine‐activated Killer Cells toward Glioma Cells by Transfection of the Killer Cells with the γ‐Interferon Gene
por: Mizuno, Masaaki, et al.
Publicado: (1995)

In vitro sensitivity of clonogenic cells in resisting and relapsing patients with acute myelogenous leukaemia.
por: Marie, J. P., et al.
Publicado: (1988)

Cannot write session to /tmp/vufind_sessions/sess_mec1irc64ub5ac3bnd6o47b56d